Forgot your password?

Forgot your username?

database > company
Ranbaxy Pharmaceuticals
Biotech Specialty Pharma
600 College Road East, Suite 2100
Princeton, NJ 08540 USA
phone:609 720 9200
fax:609 720 1155
Symbol RLL
Exchange NSE
Founded 1961
Employees
www.ranbaxyusa.com
Research Sector Biotech Specialty Pharma
Summary Description
Large pharma company based in India
Management
Mr. Atul Sobti, Chief Executive Officer & Managing Director; Mr. Arun Sawhney, President, Global Pharmaceuticals Business; Dr. Tsutomu Une, Chairman, Non Executive &, Non Independent Director; Mr. Atul Sobti, Chief Executive Officer & Managing Director; Mr. Takashi, Shoda Non Executive &Non Independent Director
 

Keywords
pharmaceutical, biologics, oncology, inorganic, generics



Comment | Printable Version | Modify profile |
Updated: Jun. 27, 2012

Description
Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. The company has a global footprint in 49 countries, world-class manufacturing facilities in 10 countries and serves customers in over 125 countries. In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd., to create an innovator and generic pharmaceutical powerhouse. Using the finest R&D and Manufacturing facilities, Ranbaxy Laboratories Limited manufacture and markets generic pharmaceuticals, value added generic pharmaceuticals, branded generics, active Pharmaceuticals (API) and intermediates. The company remains focused on ascending the value chain in the marketing of pharmaceutical substances and is determined to bring in increased revenues from dosage forms sales.
Products / Services

Ranbaxy Pharmaceuticals is a generic pharmaceutical company, with product lines of generics and OTC. The growing product line includes anti-infectives, cardiovascular medicines, NSAIDs, anti-expectora...

view more


2013-06-19-1332